Bambusa Prices Upsized Immunology IPO
Bambusa Therapeutics priced an upsized US initial public offering on 29 October at 20:15 Eastern: 10,555,555 new shares at $16, for approximately $168.9 million in expected gross proceeds before fees. The shares were scheduled…
